70.75
70.75 (0%)
As of Apr 28, 2025
Ani Pharmaceuticals Inc [ANIP]
Source:
Company Overview
ANI Pharmaceuticals, Inc. and its consolidated subsidiaries is a diversified bio-pharmaceutical company committed to its mission of “Serving Patients, Improving Lives” by developing, manufacturing, and commercializing innovative and high-quality therapeutics.
| Country | United States |
| Headquarters | baudette, minnesota |
| Phone Number | 2186343500 |
| Industry | manufacturing |
| CEO | Nikhil Lalwani |
| Website | www.anipharmaceuticals.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $614.4 |
| Operating Profit | $0.6 |
| Net Income | $-18.5 |
| Net Cash | $-76.2 |
Profit Ratios
| Gross Margin | $364.2 |
| Operating Margin | 0.1 |
| Profit as % of Revenues | -1,966.1% |
| Profit as % of Assets | -1.7% |
| Profit as % of Stockholder Equity | -4.6% |
Management Effectiveness
| Return on Equity | -4.6% |
| Return on Assets | -1.4% |
| Turnover Ratio | 56.2% |
| EBITA | $68.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,283.7 |
| Total Liabilities | $855.2 |
| Operating Cash Flow | $64 |
| Investing Cash Flow | $-404.7 |
| Financing Cash Flow | $264.9 |
